As Exelon (EXC) Market Value Declined, Prudential Plc Has Cut by $1.23 Million Its Position; Broadfin Capital Has Lowered Its Idera Pharmaceuticals (IDRA) Position by $2.85 Million as Shares Declined

January 14, 2018 - By Stephen Andrade

Prudential Plc decreased its stake in Exelon Corp (EXC) by 7.87% based on its latest 2017Q3 regulatory filing with the SEC. Prudential Plc sold 33,159 shares as the company’s stock declined 1.46% while stock markets rallied. The hedge fund held 388,368 shares of the power generation company at the end of 2017Q3, valued at $14.63 million, down from 421,527 at the end of the previous reported quarter. Prudential Plc who had been investing in Exelon Corp for a number of months, seems to be less bullish one the $36.89B market cap company. The stock decreased 0.05% or $0.02 during the last trading session, reaching $38.39. About 5.10 million shares traded. Exelon Corporation (NYSE:EXC) has risen 2.57% since January 14, 2017 and is uptrending. It has underperformed by 14.13% the S&P500.

Kevin Kotler decreased its stake in Idera Pharmaceuticals Inc (IDRA) by 36.93% based on its latest 2017Q3 regulatory filing with the SEC. Broadfin Capital Llc sold 1.42M shares as the company’s stock declined 1.15% while stock markets rallied. The hedge fund run by Kevin Kotler held 2.43 million shares of the health care company at the end of 2017Q3, valued at $5.42 million, down from 3.85 million at the end of the previous reported quarter. Broadfin Capital Llc who had been investing in Idera Pharmaceuticals Inc for a number of months, seems to be less bullish one the $485.23M market cap company. The stock increased 4.18% or $0.1 during the last trading session, reaching $2.49. About 1.83M shares traded. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has risen 21.13% since January 14, 2017 and is uptrending. It has outperformed by 4.43% the S&P500.

Since October 26, 2017, it had 1 insider purchase, and 1 insider sale for $7.48 million activity. The insider BAKER BROS. ADVISORS LP bought 8.00 million shares worth $12.00M.

Investors sentiment decreased to 1.36 in 2017 Q3. Its down 0.10, from 1.46 in 2017Q2. It fall, as 5 investors sold IDRA shares while 20 reduced holdings. 11 funds opened positions while 23 raised stakes. 46.97 million shares or 1.60% more from 46.23 million shares in 2017Q2 were reported. Alps Advsr accumulated 147,363 shares. Alyeska Investment Grp Ltd Partnership holds 0.01% or 635,853 shares. Legal & General Grp Public Ltd Co owns 29,020 shares. Royal Financial Bank Of Canada, a Ontario – Canada-based fund reported 21,719 shares. State Of Wisconsin Invest Board has invested 0% of its portfolio in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Credit Suisse Ag holds 0% or 72,576 shares in its portfolio. Susquehanna Intl Group Limited Liability Partnership stated it has 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). State Board Of Administration Of Florida Retirement Systems reported 19,240 shares stake. 72,387 are owned by Amer Interest Group. Natl Bank Of America Corp De owns 0% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 11,247 shares. Moreover, Goldman Sachs Grp Inc Inc has 0% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 11,233 shares. Ameritas Investment Partners Inc owns 7,586 shares for 0% of their portfolio. Natixis has 0.07% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 3.16M shares. Creative Planning owns 0% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for 43,600 shares. California State Teachers Retirement System holds 171,055 shares or 0% of its portfolio.

Analysts await Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) to report earnings on March, 21. They expect $-0.08 EPS, down 900.00% or $0.09 from last year’s $0.01 per share. After $-0.10 actual EPS reported by Idera Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -20.00% EPS growth.

Among 4 analysts covering Idera Pharma (NASDAQ:IDRA), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Idera Pharma had 7 analyst reports since January 6, 2016 according to SRatingsIntel. The stock of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) earned “Outperform” rating by Wedbush on Wednesday, January 6. The firm earned “Outperform” rating on Wednesday, February 1 by Wedbush. The firm has “Buy” rating given on Thursday, November 16 by H.C. Wainwright. The rating was maintained by Piper Jaffray on Thursday, November 9 with “Buy”. Piper Jaffray maintained the shares of IDRA in report on Monday, September 11 with “Buy” rating.

Broadfin Capital Llc, which manages about $1.26B and $676.01M US Long portfolio, upped its stake in La Jolla Pharmaceutical Co (NASDAQ:LJPC) by 908,138 shares to 1.06M shares, valued at $36.80M in 2017Q3, according to the filing. It also increased its holding in Nuvasive Inc (NASDAQ:NUVA) by 32,100 shares in the quarter, for a total of 88,000 shares, and has risen its stake in Iovance Biotherapeutics Inc.

Investors sentiment decreased to 1.05 in Q3 2017. Its down 0.09, from 1.14 in 2017Q2. It fall, as 48 investors sold EXC shares while 239 reduced holdings. 63 funds opened positions while 237 raised stakes. 726.69 million shares or 0.50% more from 723.10 million shares in 2017Q2 were reported. Smithfield Trust has 0.02% invested in Exelon Corporation (NYSE:EXC). Shine Investment Advisory has 1,013 shares. Advsr Limited Limited Liability Com has invested 0% in Exelon Corporation (NYSE:EXC). Renaissance Techs Ltd Llc invested 0.07% in Exelon Corporation (NYSE:EXC). Usa Fincl Portformulas reported 7,432 shares. Checchi Advisers Limited Com has 0.03% invested in Exelon Corporation (NYSE:EXC) for 7,534 shares. Ls Invest Advsrs Ltd has invested 0.08% in Exelon Corporation (NYSE:EXC). Retirement Systems Of Alabama reported 465,789 shares stake. 3,003 were accumulated by Live Your Vision Ltd Liability. Waddell & Reed Fincl Incorporated has invested 0.12% in Exelon Corporation (NYSE:EXC). Brown Advisory invested 0% of its portfolio in Exelon Corporation (NYSE:EXC). Kentucky-based Mcf Lc has invested 0% in Exelon Corporation (NYSE:EXC). Metropolitan Life Insur invested in 0.11% or 455,899 shares. Moreover, Kistler has 0.11% invested in Exelon Corporation (NYSE:EXC) for 6,928 shares. First Interstate Bancshares reported 1.18% of its portfolio in Exelon Corporation (NYSE:EXC).

Analysts await Exelon Corporation (NYSE:EXC) to report earnings on February, 14. They expect $0.60 EPS, up 36.36% or $0.16 from last year’s $0.44 per share. EXC’s profit will be $576.51 million for 16.00 P/E if the $0.60 EPS becomes a reality. After $0.85 actual EPS reported by Exelon Corporation for the previous quarter, Wall Street now forecasts -29.41% negative EPS growth.

Among 21 analysts covering Exelon Corporation (NYSE:EXC), 13 have Buy rating, 3 Sell and 5 Hold. Therefore 62% are positive. Exelon Corporation had 65 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Deutsche Bank to “Buy” on Friday, July 22. On Monday, March 7 the stock rating was upgraded by Argus Research to “Buy”. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, December 13. SunTrust maintained Exelon Corporation (NYSE:EXC) rating on Wednesday, October 18. SunTrust has “Buy” rating and $43.0 target. The stock has “Buy” rating by Jefferies on Wednesday, October 11. Morgan Stanley reinitiated Exelon Corporation (NYSE:EXC) on Wednesday, April 6 with “Equal-Weight” rating. The firm earned “Buy” rating on Friday, May 26 by Credit Suisse. The firm earned “Buy” rating on Sunday, November 5 by RBC Capital Markets. The stock of Exelon Corporation (NYSE:EXC) has “Neutral” rating given on Monday, April 11 by Goldman Sachs. The company was maintained on Monday, January 8 by SunTrust.

Since September 11, 2017, it had 0 insider purchases, and 3 selling transactions for $24.20 million activity. 25,000 Exelon Corporation (NYSE:EXC) shares with value of $936,000 were sold by Cornew Kenneth W.. Aliabadi Paymon sold 13,333 shares worth $510,787.

Prudential Plc, which manages about $98.23 billion and $31.69 billion US Long portfolio, upped its stake in Wells Fargo & Co (NYSE:WFC) by 654,883 shares to 14.81 million shares, valued at $817.03 million in 2017Q3, according to the filing. It also increased its holding in News Corp New (NASDAQ:NWSA) by 29,880 shares in the quarter, for a total of 359,433 shares, and has risen its stake in Tiffany & Co (NYSE:TIF).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: